T-cell receptor pathway may be correlated with the pathogenesis of extranodal NK/T-cell lymphoma, and the inducible T cell kinase (ITK) involved in T-cell receptor pathway may serve as a candidate target for treating the lymphoma patients expressing ITK (Tomoko et al., 2018). This evidence concerns the gene ITK and lymphoma.